Skip to main navigation Skip to search Skip to main content

Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement

  • Julian Maier*
  • , Thomas Lambert
  • , Thomas Senoner
  • , Stephan Dobner
  • , Uta C. Hoppe
  • , Alexander Fellner
  • , Bernhard Erich Pfeifer
  • , Clemens Steinwender
  • , Gudrun Maria Feuchtner
  • , Guy Friedrich
  • , Severin Semsroth
  • , Nikolaos Bonaros
  • , Johannes Holfeld
  • , Silvana Müller
  • , Markus Reinthaler
  • , Fabian Barbieri*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

INTRODUCTION: Previous analyses have reported the outcomes of transcatheter aortic valve replacement (TAVR) for patients with low-flow, low-gradient (LFLG) aortic stenosis (AS), without stratifying according to the route of access. Differences in mortality rates among access routes have been established for high-gradient (HG) patients and hypothesized to be even more pronounced in LFLG AS patients. This study aims to compare the outcomes of patients with LFLG or HG AS following transfemoral (TF) or transapical (TA) TAVR.

METHODS: A total of 910 patients, who underwent either TF or TA TAVR with a median follow-up of 2.22 (IQR: 1.22-4.03) years, were included in this multicenter cohort study. In total, 146 patients (16.04%) suffered from LFLG AS. The patients with HG and LFLG AS were stratified according to the route of access and compared statistically.

RESULTS: The operative mortality rates of patients with HG and LFLG were found to be comparable following TF access. The operative mortality rate was significantly increased for patients who underwent TA access [odds ratio (OR): 2.91 (1.54-5.48), p  = 0.001] and patients with LFLG AS [OR: 2.27 (1.13-4.56), p  = 0.02], which could be corroborated in a propensity score-matched subanalysis. The observed increase in the risk of operative mortality demonstrated an additive effect [OR for TA LFLG: 5.45 (2.35-12.62), p  < 0.001]. LFLG patients who underwent TA access had significantly higher operative mortality rates (17.78%) compared with TF LFLG (3.96%, p  = 0.016) and TA HG patients (6.36%, p  = 0.024).

CONCLUSIONS: HG patients experienced a twofold increase in operative mortality rates following TA compared with TF access, while LFLG patients had a fivefold increase in operative mortality rates. TA TAVR appears suboptimal for patients with LFLG AS. Prospective studies should be conducted to evaluate alternative options in cases where TF is not possible.

Original languageEnglish
Article number1256112
Number of pages5
JournalFrontiers in Cardiovascular Medicine
Volume10
DOIs
Publication statusPublished - Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fields of science

  • 303 Health Sciences
  • 304 Medical Biotechnology
  • 305 Other Human Medicine, Health Sciences
  • 301 Medical-Theoretical Sciences, Pharmacy
  • 302 Clinical Medicine
  • 302032 Cardiology
  • 302031 Intensive care medicine
  • 302030 Internal medicine

Cite this